Anti-Insulin Receptor beta antibody [C18C4]
- BOND RX™ Validated
- What is this?
3
(2 Reviews)
|
(50 Publications)
Mouse Monoclonal Insulin Receptor beta antibody. Suitable for IHC-P, Flow Cyt, WB and reacts with Human, Mouse, Rat samples. Cited in 40 publications. Immunogen corresponding to Recombinant Fragment Protein within Human INSR.
View Alternative Names
CD220, Insulin receptor, IR
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Insulin Receptor beta antibody [C18C4] (AB69508)
IHC image of ab69508 staining in human normal kidney formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab69508, 1μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
This image was generated using the ascites version of the product.
- Flow Cyt
Unknown
Flow Cytometry - Anti-Insulin Receptor beta antibody [C18C4] (AB69508)
Overlay histogram showing HepG2 cells stained with ab69508 (red line). The cells were fixed with 80% methanol (5 min) and incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab69508, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
Please note that Abcam do not have any data for use of this antibody on non-fixed cells. We welcome any customer feedback.
This image was generated using the ascites version of the product.
- WB
Supplier Data
Western blot - Anti-Insulin Receptor beta antibody [C18C4] (AB69508)
This image was generated using the ascites version of the product.
All lanes:
Western blot - Anti-Insulin Receptor beta antibody [C18C4] (ab69508) at 1/1000 dilution
Lane 2:
HeLa lysate (Human epithelial cell line from cervix adenocarcinoma)
Lane 3:
MCF-7 lysate (Human breast adenocarcinoma cell line)
Lane 4:
PC-12 lysate (Rat adrenal gland pheochromocytoma cell line)
Lane 5:
3T3-L1 lysate (Mouse embryonic fibroblast cell line)
Predicted band size: 95 kDa
Observed band size: 98 kDa
true
- WB
CiteAb
Western blot - Anti-Insulin Receptor beta antibody [C18C4] (AB69508)
Insulin Receptor beta western blot using anti-Insulin Receptor beta antibody [C18C4] ab69508. Publication image and figure legend from Shih, C. K., Chen, C. M., et al., 2020, Food Nutr Res, PubMed 32425738.
ab69508 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab69508 please see the product overview.
Expression of insulin-signaling-related proteins in the muscle. Protein expression of p-IR & IR (panel a), p-Akt & Akt (panel b), and M-GLUT4 & T-GLU4 (panel c) were analyzed with Western blot of the homogenates in the gastrocnemius muscle. Data are expressed as means ± standard deviations (n = 5). p-IR, phospho-insulin receptor; IR, insulin receptor; p-Akt, phospho-protein kinase B; Akt, protein kinase B; M-GLU4, membrane glucose transporter 4; T-GLU4, total glucose transporter 4; Asterisks indicate significant difference compared to DM group. Statistical evaluation was performed using one-way ANOVA, followed by Duncan's multiple range test, p < 0.05.
false
Reactivity data
Product details
Properties and storage information
Form
Purity
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The function of insulin receptor beta involves both glucose homeostasis and growth regulation as part of the tetrameric insulin receptor complex. Upon insulin binding to the receptor IR beta undergoes autophosphorylation leading to the recruitment and phosphorylation of various intracellular substrates. This interaction plays a critical role in mediating the effects of insulin such as promoting glucose uptake in cells and modulating lipid metabolism. This receptor subunit is also referred to in studies as insulin 44 or insulin 37 referring to different conceptual sizes or regulatory stages.
Pathways
The insulin signaling pathway represents the main route facilitated by insulin receptor beta. This pathway is essential for regulating glucose transport lipid metabolism and protein synthesis. Perturbations in this cascade are commonly associated with insulin resistance. The insulin receptor beta interacts with other proteins like insulin receptor substrates (IRS) during this pathway which subsequently activate key downstream pathways such as the PI3K-AKT pathway critical for cell survival and growth. This protein also plays a role in MAP kinase signaling through which it impacts gene expression related to cell growth.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (50)
Recent publications for all applications. Explore the full list and refine your search
iScience 28:112354 PubMed40330888
2025
Applications
Unspecified application
Species
Unspecified reactive species
Methods in molecular biology (Clifton, N.J.) 2882:179-193 PubMed39992510
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cells 13: PubMed38667300
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular nutrition & food research 68:e2200842 PubMed37990402
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular biology of the cell 34:ar124 PubMed37703099
2023
Applications
Unspecified application
Species
Unspecified reactive species
British journal of cancer 129:521-530 PubMed37355721
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in endocrinology 14:1127524 PubMed37008907
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental biology and medicine (Maywood, N.J.) 248:339-349 PubMed36740767
2023
Applications
Unspecified application
Species
Unspecified reactive species
Genetics research 2022:1500768 PubMed36325267
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in veterinary science 9:912721 PubMed36176700
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com